Home/Filings/4/0001140361-17-034304
4//SEC Filing

Telkamp Bruce 4

Accession 0001140361-17-034304

CIK 0001561387other

Filed

Sep 4, 8:00 PM ET

Accepted

Sep 5, 4:16 PM ET

Size

17.6 KB

Accession

0001140361-17-034304

Insider Transaction Report

Form 4
Period: 2017-09-01
Telkamp Bruce
DirectorChief Operating Officer
Transactions
  • Exercise/Conversion

    Class A Common Stock

    2017-09-01$12.13/sh+2,000$24,26019,500 total
  • Exercise/Conversion

    Class A Common Stock

    2017-09-01$4.95/sh+10,000$49,50027,500 total
  • Exercise/Conversion

    Stock Appreciation Rights

    2017-09-012,0004,000 total
    Exercise: $12.13Exp: 2021-07-14Class A Common Stock (2,000 underlying)
  • Sale

    Class A Common Stock

    2017-09-01$36.19/sh1,332$48,20317,500 total
  • Disposition to Issuer

    Class A Common Stock

    2017-09-01$36.19/sh1,362$49,28926,138 total
  • Sale

    Class A Common Stock

    2017-09-01$36.19/sh8,638$312,59617,500 total
  • Disposition to Issuer

    Class A Common Stock

    2017-09-01$36.19/sh668$24,17418,832 total
  • Exercise/Conversion

    Stock Appreciation Rights

    2017-09-0110,00020,000 total
    Exercise: $4.95Exp: 2022-07-01Class A Common Stock (10,000 underlying)
Footnotes (4)
  • [F1]These stock-settled stock appreciation rights were previously granted under the Issuer's Long Term Incentive Plan, as amended ("Plan"), and are scheduled to vest in increments of 20%, 20%, 20% and 40% on successive anniversary dates of the grant, subject to the terms of the Plan and an award agreement under the Plan.
  • [F2]These stock-settled stock appreciation rights were previously granted under the Plan and are scheduled to vest in increments of 25%, 25%, and 50% on successive anniversary dates of the grant, subject to the terms of the Plan and an award agreement under the Plan.
  • [F3]Shares retained by the issuer to satisfy the exercise price of stock appreciation rights exercised by the reporting person.
  • [F4]The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $36.00 to $36.35, inclusive. The Reporting Person undertakes to provide Health Insurance Innovations Inc. (the "Company"), any security holder of the Company, or the staff of the Securities & Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein.

Documents

1 file

Issuer

Health Insurance Innovations, Inc.

CIK 0001561387

Entity typeother

Related Parties

1
  • filerCIK 0001366007

Filing Metadata

Form type
4
Filed
Sep 4, 8:00 PM ET
Accepted
Sep 5, 4:16 PM ET
Size
17.6 KB